AbbVie Inc. Operating Cash Flow 2011-2025 | ABBV
Beta
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is AbbVie Inc.'s current operating cash flow?
AbbVie Inc. (ABBV) annual operating cash flow for 2024 was $18.81B, a 17.66% decline from 2023. AbbVie Inc. operating cash flow for the quarter ending September 30, 2025 was $7.02B.
What was AbbVie Inc.'s operating cash flow in 2023?
AbbVie Inc. annual operating cash flow for 2023 was $22.84B, a 8.44% decline from 2022.
What was AbbVie Inc.'s operating cash flow in 2022?
AbbVie Inc. annual operating cash flow for 2022 was $24.94B, a 9.51% increase from 2021.
What is AbbVie Inc.'s 5-year operating cash flow CAGR?
AbbVie Inc. operating cash flow grew at a compound annual growth rate (CAGR) of 7.14% from FY2019 to FY2024, going from $13.32B to $18.81B over 5 years.
Operating Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR+7.1%
FY2019
$13.32B
→
FY2024
$18.81B
1112131415161718192021222324
5 years selected
Operating Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $18.81B | -17.7% | 10-K |
| FY2023 | $22.84B | -8.4% | 10-K |
| FY2022 | $24.94B | +9.5% | 10-K |
| FY2021 | $22.78B | +29.5% | 10-K |
| FY2020 | $17.59B | +32.0% | 10-K |
| FY2019 | $13.32B | -0.8% | 10-K |
| FY2018 | $13.43B | +34.8% | 10-K |
| FY2017 | $9.96B | +41.5% | 10-K |
| FY2016 | $7.04B | -6.6% | 10-K |
| FY2015 | $7.54B | +112.3% | 10-K |
| FY2014 | $3.55B | -43.4% | 10-K |
| FY2013 | $6.27B | -1.2% | 10-K |
| FY2012 | $6.34B | +1.6% | 10-K |
| FY2011 | $6.25B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →